Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6
Top Cited Papers
Open Access
- 1 June 2003
- journal article
- method
- Published by Elsevier in Molecular Therapy
- Vol. 7 (6) , 839-850
- https://doi.org/10.1016/s1525-0016(03)00095-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteinsJournal of Clinical Investigation, 2002
- Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a modelHuman Molecular Genetics, 2001
- Adeno-Associated Virus Type 6 (AAV6) Vectors Mediate Efficient Transduction of Airway Epithelial Cells in Mouse Lungs Compared to That of AAV2 VectorsJournal of Virology, 2001
- Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene TransferJournal of Virology, 2001
- Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype VectorsMolecular Therapy, 2000
- Nonrandom Transduction of Recombinant Adeno-Associated Virus Vectors in Mouse Hepatocytes In Vivo: Cell Cycling Does Not Influence Hepatocyte TransductionJournal of Virology, 2000
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous systemProceedings of the National Academy of Sciences, 2000
- Progress in Adeno-Associated Virus Type 2 Vector Production: Promises and Prospects for Clinical UseHuman Gene Therapy, 1999
- Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)Journal of Medical Virology, 1999